J. Goldman & Co’s Celgene Corporation Contingent Value Rights CELGZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q4
Sell
-40,000
Closed -$322K 285
2013
Q3
$322K Buy
+40,000
New +$322K 0.03% 144